SUPN Supernus Pharmaceuticals Inc

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders.

$33.86  +0.58 (1.74%)
As of 09/30/2022 15:59:57 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Drug Manufacturers—Specialty &
Index country:  USA
Country of incorporation:  USA
IPO date:  05/01/2012
Outstanding shares:  53,495,261
Average volume:  429,464
Market cap:   $1,780,322,286
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      B72ZBG4
Valuation   (See tab for details)
PE ratio:   36.09
PB ratio:   2.18
PS ratio:   2.93
Return on equity:   6.15%
Net income %:   8.25%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy